TRIUMEQ 5 MG/60 MG/30 MG COMPRIMIDOS DISPERSABLES
TRIUMEQ 5 MG/60 MG/30 MG COMPRIMIDOS DISPERSABLES
Commercialized
Register Number
1140940003
Prescription Type
Diagnóstico Hospitalario
Authorization Date
May 24, 2023
Dosage Form
COMPRIMIDO DISPERSABLE
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number1140940003
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (3)
ABACAVIR SULFATOActive
Quantity: 70,20 mg
Name: ABACAVIR SULFATO
DOLUTEGRAVIR SODIOActive
Quantity: 5,26 mg
Name: DOLUTEGRAVIR SODIO
LAMIVUDINAActive
Quantity: 30 mg
Name: LAMIVUDINA
ATC CLASSIFICATION (3)
J05A
J05AR
J05AR13